A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus

Clinical trial NCT01029795 · TERMINATED

Trial details

NCT number: NCT01029795
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-02-01
Primary completion: 2010-06-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.